Common use of Sections 8 Clause in Contracts

Sections 8. 2(a) and (b) of the License Agreement are hereby deleted and replaced in their entirety as follows: (a) within thirty (30) days following the dates on which the first NDA or BLA, as applicable, for a Licensed Protein Product is filed with the FDA by Connetics for *** ; provided however, that such milestone payments shall only be paid once for each of the foregoing indications, and shall not be paid upon the filing of a NDA or BLA for an osteopetrosis or any mycobacterial infection indication. (b) within thirty (30) days following the date Connetics receives the first FDA approval of *** ; provided however, that such milestone payment shall only be paid once for each of the foregoing indications, and shall not be paid upon receipt of FDA approval for commercial sale for an osteopetrosis or any mycobacterial infection indication.

Sections 8. 2(a) and (b) of the License Agreement are hereby deleted and replaced in their entirety as follows: (a) […***…] within thirty (30) days following the dates on which the first NDA or BLA, as applicable, for a Licensed Protein Product is filed with the FDA by Connetics for […*** *…]; provided however, that such milestone payments shall only be paid once for each of the foregoing indications, and shall not be paid upon the filing of a NDA or BLA for an osteopetrosis or any mycobacterial infection indication. (b) […***…] within thirty (30) days following the date Connetics receives the first FDA approval of […*** *…]; provided however, that such milestone payment shall only be paid once for each of the foregoing indications, and shall not be paid upon receipt of FDA approval for commercial sale for an osteopetrosis or any mycobacterial infection indication.